- Home
- VANI vs ROMA Comparison
VANI vs ROMA Comparison
Compare VANI & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- ROMA
- Stock Information
- Founded
- VANI 1998
- ROMA 2018
- Country
- VANI United States
- ROMA Hong Kong
- Employees
- VANI N/A
- ROMA N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ROMA Savings Institutions
- Sector
- VANI Health Care
- ROMA Finance
- Exchange
- VANI Nasdaq
- ROMA Nasdaq
- Market Cap
- VANI 75.8M
- ROMA 150.7M
- IPO Year
- VANI 2014
- ROMA 2024
- Fundamental
- Price
- VANI $1.27
- ROMA $3.25
- Analyst Decision
- VANI Strong Buy
- ROMA
- Analyst Count
- VANI 1
- ROMA 0
- Target Price
- VANI $4.00
- ROMA N/A
- AVG Volume (30 Days)
- VANI 52.2K
- ROMA 38.8K
- Earning Date
- VANI 11-12-2025
- ROMA 09-25-2025
- Dividend Yield
- VANI N/A
- ROMA N/A
- EPS Growth
- VANI N/A
- ROMA N/A
- EPS
- VANI N/A
- ROMA N/A
- Revenue
- VANI N/A
- ROMA $1,568,345.00
- Revenue This Year
- VANI N/A
- ROMA N/A
- Revenue Next Year
- VANI N/A
- ROMA N/A
- P/E Ratio
- VANI N/A
- ROMA N/A
- Revenue Growth
- VANI N/A
- ROMA 23.21
- 52 Week Low
- VANI $0.91
- ROMA $0.54
- 52 Week High
- VANI $1.80
- ROMA $4.66
- Technical
- Relative Strength Index (RSI)
- VANI 50.75
- ROMA 60.07
- Support Level
- VANI $1.19
- ROMA $2.28
- Resistance Level
- VANI $1.40
- ROMA $3.40
- Average True Range (ATR)
- VANI 0.07
- ROMA 0.34
- MACD
- VANI 0.01
- ROMA 0.13
- Stochastic Oscillator
- VANI 50.00
- ROMA 90.80
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.